The deadline is Monday, July 15, and all submissions must be sent to firstname.lastname@example.org.
Submissions should focus on a disruptive technology related to endovascular medicine. All products should be approved within the past year or pending approval. Selected presenters will have 7 minutes to present their product. VIVA will provide 1 complimentary full access registration to the person presenting in this session. Presenters must cover their own accommodation and travel expenses. The application process is simple: send 2-3 sentences describing your product to email@example.com, and specify who will be presenting at the conference.
Notification of acceptance or rejection will be sent within two weeks of the July 15 deadline.
For additional questions, email firstname.lastname@example.org.